0001477932-21-003653.txt : 20210527
0001477932-21-003653.hdr.sgml : 20210527
20210527194019
ACCESSION NUMBER: 0001477932-21-003653
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180101
FILED AS OF DATE: 20210527
DATE AS OF CHANGE: 20210527
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Udell Mark
CENTRAL INDEX KEY: 0001490433
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55908
FILM NUMBER: 21975196
MAIL ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cure Pharmaceutical Holding Corp.
CENTRAL INDEX KEY: 0001643301
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 371765151
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
BUSINESS PHONE: 805-824-0410
MAIL ADDRESS:
STREET 1: 1620 BEACON PLACE
CITY: OXNARD
STATE: CA
ZIP: 93033
FORMER COMPANY:
FORMER CONFORMED NAME: Makkanotti Group Corp.
DATE OF NAME CHANGE: 20150526
4
1
form4.xml
FORM 4
X0306
4
2018-01-01-05:00
false
0001643301
Cure Pharmaceutical Holding Corp.
CURR
0001490433
Udell Mark
1620 BEACON PLACE
OXNARD
CA
93033
false
true
false
false
Chief Accounting Officer
Stock Option
0.74
2018-01-01-05:00
4
A
false
150000
0.00
A
2028-04-06-05:00
Common Stock
150000
150000
D
The option becomes exercisable on the basis determined by the equity incentive plan with 6.25% of the option vesting on the first quarter anniversary of vesting start date. For each additional quarter of the participant's service the option will continue to vest until the vested ratio is 100%. This late filing is due to an inadvertent administrative error and not any error of the reporting person.
/s/ Mark Udell
2021-05-27-05:00